CD24 and neoplasm: Our results indicate that CD24a knockout in 4T1 cells enhances anti-tumor immune response by increasing the abundance of immune effectors in TME and increasing tumor cell susceptibility to CD8+ T cells-mediated cytotoxicity and macrophages-mediated phagocytosis.